Showing results (571-580 of 745) with videos related to

Sort By:
Pageof 75
Plos One|January 16, 2015
The diagnostic value of clinical symptoms in women and men presenting with chest pain at the emergency department, a prospective cohort studyManon G van der Meer, Barbra E Backus, Yolanda van der Graaf, et al.
Pediatric Pulmonology|July 17, 2024
Dupilumab 200 mg was efficacious in children (6-11 years) with moderate-to-severe asthma for up to 2 years: EXCURSION open-label extension studyWanda Phipatanakul, Christian Vogelberg, Leonard B Bacharier, et al.
Indian Journal of Cancer|December 5, 2017
Dual mutations and complex mutations in metastatic nonsmall cell lung cancer: A single-institution experience from South IndiaL Kadabur, D Koppaka, G B Kanakasetty, et al.
Human Reproduction (Oxford, England)|December 21, 2016
Stability of the human sperm DNA methylome to folic acid fortification and short-term supplementationD Chan, S McGraw, K Klein, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|March 6, 2023
Dupilumab long-term efficacy in patients with non-OCS-dependent asthma with and without evidence of allergic asthmaLawrence D Sher, Jonathan Corren, Ian D Pavord, et al.
ERJ Open Research|December 17, 2024
Long-term dupilumab efficacy in type 2 asthma regardless of baseline characteristicsMichael E Wechsler, Linda Rogers, G Walter Canonica, et al.
The American Surgeon|December 8, 2023
The Upstate New York Surgical Quality Improvement Opioid Reduction ProjectElizabeth A Jacob, Alexa D Melucci, Ethan A Talbot, et al.
The American Journal of Clinical Nutrition|December 1, 1991
Immunocompetence and oxidant defense during ascorbate depletion of healthy menR A Jacob, D S Kelley, F S Pianalto, et al.
The American Journal of Clinical Nutrition|October 1, 1978
Influence of dietary fiber on trace element balanceH H Sandstead, J M Muñoz, R A Jacob, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|September 16, 2022
Efficacy of dupilumab in patients with uncontrolled, moderate-to-severe asthma recruited from Japanese centers in the phase 3 LIBERTY ASTHMA TRAVERSE studyYuji Tohda, Yoichi Nakamura, Takao Fujisawa, et al.
Pageof 75